Postoperative clinical outcomes of patients with thymic epithelial tumors after over-3-year follow-up at a single-center

Table 4 Analysis of factors influencing postoperative MG treatment in thymoma patients with MG

Variables	Univariate model			Multivariate model
Variables	OR	95% CI	P value	OR	95% CI	P value
Sex
Female	Reference
Male	0.972	0.666–1.420	0.884
Age	1.006	0.993–1.020	0.357
Preoperative course
< 12 month	Reference
≥ 12 month	0.823	0.498–1.359	0.447
Application of hormone	0.821	0.414–1.628	0.572
Application of immunosuppressants	1.001	0.501–1.997	0.998
Osserman classification
I + IIA	Reference
IIB + III + IV	0.836	0.569–1.2	0.361
WHO pathological classification
A + AB + MNT	Reference			Reference
B + MIX	0.508	0.321–0.904	0.019	0.600	0.355–1.013	0.056
Masaoka-Koga staging
I + II	Reference			Reference
III + IV	0.547	0.345–0.866	0.010	0.583	0.366–0.929	0.023
Surgical approach
OT	Reference
VATS	1.271	0.235	0.856–1.886
Resection status
R0	Reference
None R0	0.493	0.198–1.224	0.127
Perioperative complications	0.912	0.548–1.518	0.723
Postoperative therapy	0.872	0.589–1.2	0.495

Variables	Univariate model			Multivariate model
Variables	OR	95% CI	P value	OR	95% CI	P value
Sex
Female	Reference
Male	0.972	0.666–1.420	0.884
Age	1.006	0.993–1.020	0.357
Preoperative course
< 12 month	Reference
≥ 12 month	0.823	0.498–1.359	0.447
Application of hormone	0.821	0.414–1.628	0.572
Application of immunosuppressants	1.001	0.501–1.997	0.998
Osserman classification
I + IIA	Reference
IIB + III + IV	0.836	0.569–1.2	0.361
WHO pathological classification
A + AB + MNT	Reference			Reference
B + MIX	0.508	0.321–0.904	0.019	0.575	0.341–0.970	0.038
TNM staging
I + II	Reference			Reference
III + IV	0.612	0.380–0.988	0.045	0.649	0.401–1.053	0.080
Surgical approach
OT	Reference
VATS	1.271	0.856–1.886	0.235
Resection status
R0	Reference
None R0	0.493	0.198–1.224	0.127
Perioperative complications	0.912	0.548–1.518	0.723
Postoperative therapy	0.872	0.589–1.2	0.495

ISSN: 1749-8090